Founding Sponsors Complete Full Exit, Ending Governance Rights

summarizeSummary

Sotera Health's founding private equity sponsors have completed the sale of their remaining 31.8 million shares for approximately $483 million, ending their ownership and terminating their special corporate governance rights.

check_boxKey Events

• Sponsors Complete Full Divestment

  Founding private equity sponsors, Warburg Pincus and GTCR, sold their remaining 31.8 million shares, completing their exit from the company.

• Significant Secondary Offering

  The sale of 31.8 million shares at $15.168 per share generated approximately $483 million, representing about 11% of the company's market capitalization.

• Termination of Stockholders' Agreement

  As a direct result of the sponsors' complete exit, the Stockholders' Agreement, which granted them special corporate governance rights, has terminated.

• No Proceeds to Company

  The company did not issue any new shares in this transaction and will not receive any proceeds from the secondary offering.

auto_awesomeAnalysis

This 8-K formalizes the complete exit of Sotera Health's founding private equity sponsors, Warburg Pincus and GTCR, through the sale of their remaining 31.8 million shares. This transaction, valued at approximately $483 million, represents a significant portion of the company's market capitalization and marks a major shift in its ownership structure. Crucially, the completion of this sale triggers the termination of the Stockholders' Agreement, ending the sponsors' special corporate governance rights, including their ability to designate board members. This event concludes a series of distributions by these large institutional holders, removing a significant overhang but also signaling a complete divestment by the original backers.